Jessica Perrin
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Ubiquitin and proteasome pathways, Cytokine Signaling Pathways and Interactions, Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors
Most-Cited Works
- → Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors(2007)1,041 cited
- → Identifying drug targets in tissues and whole blood with thermal-shift profiling(2020)188 cited
- → Chemoproteomics-Based Design of Potent LRRK2-Selective Lead Compounds That Attenuate Parkinson’s Disease-Related Toxicity in Human Neurons(2011)149 cited
- → A selective inhibitor reveals PI3Kγ dependence of TH17 cell differentiation(2012)143 cited
- → Chemical Proteomics Reveals Ferrochelatase as a Common Off-target of Kinase Inhibitors(2016)108 cited
- → Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor(2019)87 cited
- → Drug Target Identification in Tissues by Thermal Proteome Profiling(2021)65 cited
- → A Selective Inhibitor Reveals Pi3Kgamma Dependence of T(H)17 Cell Differentiation.(2012)24 cited
- → Proteome thermal stability reflects organ physiology and identifies drug-target engagement in vivo(2018)5 cited
- → Erratum: Corrigendum: A selective inhibitor reveals PI3Kγ dependence of TH17 cell differentiation(2012)4 cited